Home > Insider Trading > Filing (0001209191-10-041721)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1176268	Phd Sandra Panem	15 Skyline Drive Hawthorne NY 10532		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-08-05	160,856	$35.86	183,199	No	4	S	Indirect	Cross Atlantic
Common Stock	Disposition	2010-08-05	35,864	$36.20	147,335	No	4	S	Indirect	Cross Atlantic
Common Stock	Disposition	2010-08-06	3,280	$35.03	144,055	No	4	S	Indirect	Cross Atlantic

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Cross Atlantic
No	4	S	Indirect	Cross Atlantic
No	4	S	Indirect	Cross Atlantic

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,630	Direct

Footnotes

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.00 to $36.00 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $36.01 to $36.54 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.00 to $35.08 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Includes 109,188 shares beneficially owned by Cross Atlantic Partners IV, K/S and 34,867 shares owned by Nordea Bank Danmark, A/S. Sandra Panem, PhD, is a partner of Cross Atlantic Partners and exercises voting and investment power over these shares. Dr. Panem disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.